Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) plans to begin clinical trials of a Muse cell-based…...

Japan's leading chemical industry newspaper
Filed Under: Coronavirus, Pharma Tagged With: clinical trials, coronavirus, health care, Life Science Institute, medical, Mitsubishi Chemical Holdings, Muse cells, stem cells
Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) plans to begin clinical trials of a Muse cell-based…...